AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -66.7% | 15,181 | -24.6% | 0.00% | – |
| Q1 2022 | $9,000 | -18.2% | 20,123 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -66.7% | 20,123 | 0.0% | 0.00% | – |
| Q3 2021 | $33,000 | -2.9% | 20,123 | 0.0% | 0.00% | – |
| Q2 2021 | $34,000 | +580.0% | 20,123 | +70.5% | 0.00% | – |
| Q2 2019 | $5,000 | -28.6% | 11,799 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | +40.0% | 11,799 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -16.7% | 11,799 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | -76.9% | 11,799 | 0.0% | 0.00% | – |
| Q2 2018 | $26,000 | -84.7% | 11,799 | -96.4% | 0.00% | – |
| Q2 2017 | $170,000 | +4150.0% | 326,224 | +6345.8% | 0.00% | – |
| Q1 2017 | $4,000 | -20.0% | 5,061 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -91.7% | 5,061 | -37.1% | 0.00% | – |
| Q1 2015 | $60,000 | +122.2% | 8,050 | 0.0% | 0.00% | – |
| Q4 2014 | $27,000 | -6.9% | 8,050 | 0.0% | 0.00% | – |
| Q3 2014 | $29,000 | – | 8,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |